Greenbrier Companies Inc
GBX NYSE Railroad Equipment Financials FY2016βFY2025
What Greenbrier Companies Inc does
No business description yet.
- Legal name
- GREENBRIER COMPANIES INC
- Fiscal year ends
- August 31, 2025
- Latest annual report
- 10-K Β· Oct 28, 2025
- Accession Β· CIK
- 0001193125-25-253612
0000923120
Revenue and margins
Greenbrier Companies Inc had $3.2B of revenue in fiscal 2025, down 8.6% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 1.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$14.7M in fiscal 2025, β0.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Greenbrier Companies Inc returned $62.3M to shareholders in fiscal 2025. The diluted share count fell 0.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Greenbrier Companies Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $647M | $543M | $282M | $352M | $306M |
| Debt incl. finance leases | β | β | β | $1.8B | $1.8B |
| Net debt / EBITDA | β | β | β | 3.2x | 3.0x |
| Debt / equity | β | β | β | 1.3x | 1.1x |
| Total assets | $3.4B | $3.9B | $4.0B | $4.3B | $4.4B |
| Total liabilities | $2.1B | $2.6B | $2.7B | $2.9B | $2.8B |
| Shareholders' equity | $1.3B | $1.3B | $1.3B | $1.4B | $1.5B |
| Net debt (β = net cash) | β | β | β | $1.4B | $1.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 7 | 4 / 7 | 1 / 7 | 4 / 7 | 2 / 7 | 4 / 7 | 6 / 7 | 6 / 7 | 7 / 8 |
| Accruals ratio | β8.4% | β8.0% | 2.0% | 3.4% | β7.2% | 2.2% | 5.4% | β0.2% | β4.1% | β1.4% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.7B | $2.2B | $2.5B | $3.0B | $2.8B | $1.7B | $3.0B | $3.9B | $3.5B | $3.2B |
| Gross profit | $551M | $421M | $409M | $366M | $353M | $232M | $306M | $441M | $559M | $608M |
| Research and development | $2.7M | $4.2M | $6.0M | $5.4M | $5.8M | $6.3M | $5.4M | $4.0M | $5.2M | $5.5M |
| Operating income | $409M | $260M | $253M | $184M | $168M | $41.0M | $118M | $176M | $325M | $360M |
| Pretax income | $395M | $236M | $224M | $153M | $125M | β$8.6M | $60.6M | $91.0M | $224M | $284M |
| Income tax | $112M | $64.0M | $32.9M | $41.6M | $40.2M | β$40.2M | $18.1M | $24.6M | $62.0M | $91.4M |
| Net income | $183M | $116M | $152M | $71.1M | $49.0M | $32.4M | $46.9M | $62.5M | $160M | $204M |
| Diluted EPS | $5.73 | $3.65 | $4.68 | $2.14 | $1.46 | $0.96 | $1.40 | $1.89 | $4.96 | $6.35 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $337M | $286M | $103M | β$21.2M | $272M | β$40.5M | β$150M | $71.2M | $330M | $266M |
| Capital expenditure | $139M | $86.1M | $177M | $198M | $66.9M | $139M | $381M | $362M | $398M | $280M |
| Free cash flow | $198M | $200M | β$73.5M | β$219M | $205M | β$180M | β$531M | β$291M | β$68.7M | β$14.7M |
| Depreciation and amortization | $63.3M | $65.1M | $74.4M | $83.7M | $110M | $101M | $102M | $106M | $116M | $122M |
| Stock-based compensation | $24.0M | $26.4M | $29.3M | $11.2M | $9.0M | $14.7M | $15.5M | $12.1M | $17.1M | $17.5M |
| Acquisitions | β | $27.1M | $34.9M | $362M | β | β | β | β | β | β |
| Share buybacks | $33.5M | β | β | β | β | $20.0M | β | $56.9M | $1.3M | $22.7M |
| Dividends paid | $23.3M | $24.9M | $29.9M | $33.2M | $35.2M | $35.6M | $35.8M | $36.1M | $38.4M | $39.6M |
| Dividends and buybacks | $56.8M | $24.9M | $29.9M | $33.2M | $35.2M | $55.6M | $35.8M | $93.0M | $39.7M | $62.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $223M | $611M | $531M | $330M | $834M | $647M | $543M | $282M | $352M | $306M |
| Total debt | β | β | β | β | β | β | β | β | $1.8B | $1.8B |
| Inventory | $366M | $400M | $432M | $665M | $530M | $574M | $815M | $824M | $771M | $688M |
| Property and equipment, net | $330M | $428M | $457M | $718M | $712M | $670M | $645M | $619M | $712M | $727M |
| Goodwill | $43.3M | $68.6M | $78.2M | $130M | $130M | $132M | $127M | $129M | $129M | $130M |
| Intangible assets | $28.1M | $39.7M | $38.8M | $68.0M | $60.4M | $53.0M | $47.3M | $39.1M | $31.5M | $24.9M |
| Total assets | $1.8B | $2.4B | $2.5B | $3.0B | $3.2B | $3.4B | $3.9B | $4.0B | $4.3B | $4.4B |
| Total liabilities | $961M | $1.4B | $1.2B | $1.7B | $1.9B | $2.1B | $2.6B | $2.7B | $2.9B | $2.8B |
| Shareholders' equity | $874M | $1.0B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.4B | $1.5B |
| Margins | ||||||||||
| Gross margin | 20.6% | 19.4% | 16.2% | 12.1% | 12.6% | 13.3% | 10.3% | 11.2% | 15.8% | 18.7% |
| Operating margin | 15.2% | 12.0% | 10.0% | 6.1% | 6.0% | 2.3% | 4.0% | 4.5% | 9.2% | 11.1% |
| EBITDA margin | 17.6% | 15.0% | 13.0% | 8.8% | 10.0% | 8.1% | 7.4% | 7.2% | 12.4% | 14.9% |
| Net margin | 6.8% | 5.4% | 6.0% | 2.3% | 1.8% | 1.9% | 1.6% | 1.6% | 4.5% | 6.3% |
| FCF margin | 7.4% | 9.2% | β2.9% | β7.2% | 7.4% | β10.3% | β17.8% | β7.4% | β1.9% | β0.5% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | β | β | β | 8.4% | 8.2% |
| Return on equity | 21.0% | 12.3% | 13.4% | 5.6% | 3.8% | 2.5% | 3.6% | 4.9% | 12.2% | 14.0% |
| Return on assets | 10.0% | 5.5% | 6.2% | 2.6% | 1.6% | 1.0% | 1.3% | 1.6% | 3.9% | 4.7% |
| Return on tangible equity | 22.8% | 12.8% | 13.4% | 6.6% | 4.4% | 2.9% | 4.3% | 5.8% | 13.2% | 14.8% |
| Growth | ||||||||||
| Revenue growth | β | β19.0% | 16.1% | 20.4% | β8.0% | β37.4% | 70.4% | 32.5% | β10.1% | β8.6% |
| Net income growth | β | β36.6% | 30.8% | β53.2% | β31.1% | β33.9% | 44.8% | 33.3% | 156.2% | 27.5% |
| EPS growth | β | β36.3% | 28.2% | β54.3% | β31.8% | β34.2% | 45.8% | 35.0% | 162.4% | 28.0% |
| FCF growth | β | 0.7% | β136.8% | β | β | β187.4% | β | β | β | β |
| Share count change | β | 0.3% | 0.8% | 1.0% | 0.8% | 0.7% | β0.1% | 0.5% | β4.2% | β0.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β | β | β | β | 3.2x | 3.0x |
| Debt / equity | β | β | β | β | β | β | β | β | 1.3x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.2% | 4.0% | 7.0% | 6.5% | 2.4% | 8.0% | 12.8% | 9.2% | 11.2% | 8.7% |
| Stock comp / revenue | 0.9% | 1.2% | 1.2% | 0.4% | 0.3% | 0.8% | 0.5% | 0.3% | 0.5% | 0.5% |
| Payouts / FCF | 28.7% | 12.5% | β | β | 17.1% | β | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 4.0 | 1.0 | 4.0 | 2.0 | 4.0 | 6.0 | 6.0 | 7.0 |
| Accruals ratio | β8.4% | β8.0% | 2.0% | 3.4% | β7.2% | 2.2% | 5.4% | β0.2% | β4.1% | β1.4% |
Source: SEC EDGAR XBRL filings (CIK 0000923120). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.